The Expression of Epidermal Growth Factor Receptor, HER-2/Neu,p53, and Ki-67 Antigen in Uterine Malignant Mixed Mesodermal Tumors and Adenosarcoma

MLA

Howard G. Muntz, et al. “The Expression of Epidermal Growth Factor Receptor, HER-2/Neu,P53, and Ki-67 Antigen in Uterine Malignant Mixed Mesodermal Tumors and Adenosarcoma.” Gynecologic Oncology, vol. 60, Jan. 1996, pp. 81–88. EBSCOhost, https://doi.org/10.1006/gyno.1996.0015.

APA

Howard G. Muntz, Joanna M. Cain, Benjamin E. Greer, Marit Ek, Elizabeth M. Swisher, Hisham K. Tamimi, Barbara A. Goff, Allen M. Gown, & Marilyn Skelly. (1996). The Expression of Epidermal Growth Factor Receptor, HER-2/Neu,p53, and Ki-67 Antigen in Uterine Malignant Mixed Mesodermal Tumors and Adenosarcoma. Gynecologic Oncology, 60, 81–88. https://doi.org/10.1006/gyno.1996.0015

Chicago

Howard G. Muntz, Joanna M. Cain, Benjamin E. Greer, Marit Ek, Elizabeth M. Swisher, Hisham K. Tamimi, Barbara A. Goff, Allen M. Gown, and Marilyn Skelly. 1996. “The Expression of Epidermal Growth Factor Receptor, HER-2/Neu,P53, and Ki-67 Antigen in Uterine Malignant Mixed Mesodermal Tumors and Adenosarcoma.” Gynecologic Oncology 60 (January): 81–88. doi:10.1006/gyno.1996.0015.